SCHEMBL24258486

SCHEMBL24258486

C=C(NC)N1CCCc2ccc(-c3c(C)ccc(-c4cnn(C)c4)c3C(F)F)cc2C1

nearest known ligand 0.61

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 19/20 0.61
BRD4 O60885 1/20 0.40
AXL P30530 1/20 0.37
TYRO3 Q06418 1/20 0.37
MERTK Q12866 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258489 0.84 CREBBP (0.56) CREBBPBRD4AXLTYRO3MERTK
SCHEMBL19657733 0.78 CREBBP (0.50) CREBBPAXLTYRO3MERTK
SCHEMBL19657581 0.77 CREBBP (0.58) CREBBP
SCHEMBL30117226 0.76 CREBBP (1.00) CREBBPBRD4
SCHEMBL19643782 0.76 CREBBP (1.00) CREBBPBRD4
SCHEMBL24258490 0.75 CREBBP (0.43) CREBBPBRD4
SCHEMBL19657724 0.72 CREBBP (0.50) CREBBPBRD4
SCHEMBL19657625 0.72 CREBBP (0.73) CREBBPBRD4
SCHEMBL19644201 0.69 CREBBP (0.76) CREBBPBRD4
SCHEMBL24258523 0.69 GPR142 (0.35) CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464270-B1 HETEROCYCLIC INHIBITORS OF CBP/EP300 AND THEIR USE IN THE TREATMENT OF CANCER GENENTECH INC (US) 2022-02-23 EP disclosed